An adjuvant for an RSV prefusion f vaccine that safely protects infants via maternal vaccination
Ended Project Grant Awarded Last action
- Award ID
- R43AI140941
- Recipient
-
Calder Biosciences Inc. UEI YZYMDHZG3ZN7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,742
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $299,955 | |
| Original award | $299,787 |
Quick answers
Who received award R43AI140941?
R43AI140941 was awarded to Calder Biosciences Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 5, 2018.
How much is award R43AI140941 worth?
$599,742 has been obligated on R43AI140941.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award